Well before Merck recalled Vioxx, our lawyers were at the forefront of Vioxx litigation. We filed one of the first Vioxx cases against Merck and began the painstaking process of reviewing millions of pages of documents and deposing key Merck personnel.

In April 2006, our lawyers obtained a $32,000,000 verdict against Merck in the case of Felicia Garza, et.al. v. Merck & Co., Inc. It was the first Vioxx verdict in the country involving short term usage of Vioxx.

Joe Escobedo has been appointed to the Discovery Committee in the Federal Multi-District Litigation (MDL) for Vioxx and has spoken at various national seminars on the subject of the cardiovascular risks of COX-2 inhibitors.

Our firm has a team of experts to handle these tragic cases. As in all pharmaceutical cases, proving general and specific causation can be challenging. Our lawyers and experts are ready to review your case.